-
-
-
-
-
-
-
NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
NovaBay Pharmaceuticals Announces Approval of All Proposals at its 2024 Annual Meeting of Stockholders and Provides Other Corporate Updates
-
-
-
-
-
-
-
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
-
-
-
-
-
-
-
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
-
-
-
-
-
-
-
NovaBay Pharma (NBY) Announces Commercial Launch of Avenova Allograft
-
-
-
-
-
-
-
NovaBay Pharmaceuticals Reports Record Avenova Sales Day
-
-
-
-
-
-
-
NovaBay Pharma (NBY) Misses Q1 EPS by 32c
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

